Zentalis Pharmaceuticals Announces Fast Track Designation Granted by the U.S. FDA to ZN-c3 for the Treatment of Uterine Serous Carcinoma


You May Also Like

Orion and Propeller Health partner to bring new digital medicines to people with asthma and COPD

Orion Corporation                                  Press release  11 February 2019 at 4.00 p.m. EET Orion and Propeller ...